NO307255B1 - Nye forbindelser og antitumormidler - Google Patents

Nye forbindelser og antitumormidler

Info

Publication number: NO307255B1
Authority: NO; Norway
Prior art keywords: hydrogen atom; group; lower alkyl; alkyl group; new compounds
Prior art date: 1994-06-14

Application number

NO965305A

Other languages

English (en)

Other versions

NO965305L (no

NO965305D0 (no

Inventor

Kyoji Tomita

Katsumi Chiba

Shigeki Kashimoto

Koh-Ichiro Shibamori

Yasunori Tsuzuki

Original Assignee

Dainippon Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-14

Filing date

1996-12-11

Publication date

2000-03-06

1996-12-11 Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co

1996-12-11 Publication of NO965305D0 publication Critical patent/NO965305D0/no

1997-02-04 Publication of NO965305L publication Critical patent/NO965305L/no

2000-03-06 Publication of NO307255B1 publication Critical patent/NO307255B1/no

Links

150000001875 compounds Chemical class 0.000 title abstract 3
239000002246 antineoplastic agent Substances 0.000 title abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
125000000217 alkyl group Chemical group 0.000 abstract 3
YSLIPUSJNFIFAB-UHFFFAOYSA-N 2-oxopyridine-1-carboxylic acid Chemical class OC(=O)N1C=CC=CC1=O YSLIPUSJNFIFAB-UHFFFAOYSA-N 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO965305A 1994-06-14 1996-12-11 Nye forbindelser og antitumormidler NO307255B1 (no)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
JP15657894		1994-06-14
JP19792194		1994-07-28
JP30691494		1994-11-15
JP33995694		1994-12-28
JP8170595		1995-03-13
PCT/JP1995/001110 WO1995034559A1 (fr)	1994-06-14	1995-06-06	Nouveau compose, son procede de production et agent antitumoral

Publications (3)

Publication Number	Publication Date
NO965305D0 NO965305D0 (no)	1996-12-11
NO965305L NO965305L (no)	1997-02-04
NO307255B1 true NO307255B1 (no)	2000-03-06

Family

ID=27524935

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO965305A NO307255B1 (no)	1994-06-14	1996-12-11	Nye forbindelser og antitumormidler

Country Status (27)

Country	Link
US (1)	US5817669A (no)
EP (1)	EP0787726B1 (no)
JP (1)	JP3391796B2 (no)
KR (1)	KR100350921B1 (no)
CN (1)	CN1053668C (no)
AT (1)	ATE209645T1 (no)
AU (1)	AU679859B2 (no)
BR (1)	BR9508037A (no)
CA (1)	CA2192824C (no)
CZ (1)	CZ292631B6 (no)
DE (1)	DE69524251T2 (no)
DK (1)	DK0787726T3 (no)
ES (1)	ES2163512T3 (no)
FI (1)	FI112485B (no)
HK (1)	HK1000495A1 (no)
HU (1)	HU220072B (no)
MX (1)	MX9606331A (no)
NO (1)	NO307255B1 (no)
NZ (1)	NZ287139A (no)
PL (1)	PL181867B1 (no)
PT (1)	PT787726E (no)
RO (1)	RO117793B1 (no)
RU (1)	RU2151770C1 (no)
SI (1)	SI0787726T1 (no)
SK (1)	SK281341B6 (no)
TW (1)	TW319769B (no)
WO (1)	WO1995034559A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0212829A (pt) *	2001-09-26	2004-08-03	Bayer Pharmaceuticals Corp	Derivados de 1,8-naftiridina e seu uso para tratar diabetes e distúrbios relacionados
US6802423B2 (en) *	2002-02-20	2004-10-12	Trans Global Foods, Inc.	Disposable food delivery apparatus
US7163948B2 (en) *	2003-04-07	2007-01-16	Cylene Pharmaceuticals, Inc.	Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
US7514451B2 (en) *	2003-09-10	2009-04-07	Kyorin Pharmaceutical Co., Ltd.	7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative
DE10352979A1 (de) *	2003-11-13	2005-06-09	Merck Patent Gmbh	Pyridopyrimidinone
CA2559652C (en) *	2004-03-15	2017-02-14	Sunesis Pharmaceuticals, Inc.	Methods of using sns-595 in treating cancer
AU2013201203C1 (en) *	2004-03-15	2015-04-23	Sumitomo Dainippon Pharma Co., Ltd.	Sns-595 and methods of using the same
US7563805B2 (en) *	2005-05-19	2009-07-21	Daiichi Pharmaceutical Co., Ltd.	Tri-, tetra-substituted-3-aminopyrrolidine derivative
US20070117770A1 (en) *	2005-08-19	2007-05-24	Cylene Pharmaceuticals, Inc.	Human ribosomal DNA (rDNA) and ribosomal RNA (rRNA) nucleic acids and uses thereof
CN104873502A (zh) *	2005-09-02	2015-09-02	逊尼希思制药公司	使用(+)-1,4-二氢-7-[(3s,4s)-3-甲氧基-4-(甲氨基)-1-吡咯烷基]-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸治疗癌症的方法
US8580814B2 (en) *	2006-04-03	2013-11-12	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
AU2013219242C1 (en) *	2005-09-02	2016-09-22	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
CA2845095A1 (en) *	2005-09-02	2007-03-08	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
EP1931339B1 (en) *	2005-09-02	2018-05-16	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
US7642270B2 (en)	2005-09-14	2010-01-05	Janssen Pharmaceutica N.V.	5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase
TW200800983A (en)	2005-09-14	2008-01-01	Janssen Pharmaceutica Nv	5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
CA2622725A1 (en) *	2005-09-14	2007-03-22	Janssen Pharmaceutica N.V.	5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
BRPI0713637A2 (pt) *	2006-06-12	2012-10-23	Sunesis Pharmaceuticals Inc	composição, composto, e , método para o tratamento de cáncer
WO2008016678A2 (en) *	2006-08-01	2008-02-07	Sunesis Pharmaceuticals, Inc.	Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
US20080063642A1 (en)	2006-08-02	2008-03-13	Adelman Daniel C	Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
EP3141250A1 (en) *	2007-10-22	2017-03-15	Sunesis Pharmaceuticals, Inc.	Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
EP2649997B1 (en) *	2007-12-10	2019-01-23	Sunesis Pharmaceuticals, Inc.	(+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for use in the treatment of myelodyspastic syndrome
MX2011006974A (es) *	2008-12-31	2011-11-18	Sunesis Pharmaceuticals Inc	Metodo para preparar acido (+)-1,4-dihidro-7-[(3s,4s)-3-metoxi-4-( metilamino)-1-pirrolidinil]-4-oxo-1-) (2-tiazolil)-1, 8-naftiridin-3-carboxilico.
SG173855A1 (en)	2009-02-27	2011-09-29	Sunesis Pharmaceuticals Inc	Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
UA110465C2 (en) *	2009-09-04	2016-01-12	Sunesis Pharmaceutecals Inc	Stable sns-595 composition
TW201120037A (en) *	2009-10-26	2011-06-16	Sunesis Pharmaceuticals Inc	Compounds and methods for treatment of cancer
CN108329246B (zh)	2011-05-13	2021-02-26	阵列生物制药公司	作为trka激酶抑制剂的吡咯烷基脲和吡咯烷基硫脲化合物
CN103497186B (zh) *	2013-09-24	2015-02-25	浙江司太立制药股份有限公司	含有烷氧亚氨基取代的萘啶酮羧酸衍生物及其制备方法
AU2018238079B2 (en) *	2017-03-24	2022-03-03	Wakunaga Pharmaceutical Co., Ltd.	Novel pyridone carboxylic acid derivative or salt thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4730000A (en) *	1984-04-09	1988-03-08	Abbott Laboratories	Quinoline antibacterial compounds
EP0154780B1 (en) *	1984-01-26	1990-04-11	Abbott Laboratories	Quinoline antibacterial compounds
NZ210847A (en) *	1984-01-26	1988-02-29	Abbott Lab	Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
JPS61152682A (ja) *	1984-12-27	1986-07-11	Dainippon Pharmaceut Co Ltd	ピリドンカルボン酸誘導体、そのエステルおよびその塩
JPS61251667A (ja) *	1985-04-30	1986-11-08	Otsuka Pharmaceut Co Ltd	ベンゾヘテロ環化合物
IL79110A0 (en) *	1985-06-13	1986-09-30	Schering Corp	Polycyclic quinoline,naphthyridine and pyrazinopyridine derivatives
US4851425A (en) *	1985-06-14	1989-07-25	The Upjohn Company	Cyclopentapyrazole and tetrahydroindazole compounds and their use as anti-inflammatory and anti-allergic agents
JPS6233176A (ja) *	1985-08-05	1987-02-13	Toyama Chem Co Ltd	１，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JP2704428B2 (ja) *	1988-06-15	1998-01-26	富山化学工業株式会社	キノロンカルボン酸誘導体またはその塩
DE3906365A1 (de) *	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JPH06233176A (ja) *	1993-01-29	1994-08-19	Sony Corp	ビデオカメラ

1995
- 1995-06-06 SI SI9530567T patent/SI0787726T1/xx unknown
- 1995-06-06 WO PCT/JP1995/001110 patent/WO1995034559A1/ja active IP Right Grant
- 1995-06-06 KR KR1019960707029A patent/KR100350921B1/ko not_active IP Right Cessation
- 1995-06-06 CZ CZ19963643A patent/CZ292631B6/cs not_active IP Right Cessation
- 1995-06-06 AU AU25767/95A patent/AU679859B2/en not_active Expired
- 1995-06-06 US US08/765,232 patent/US5817669A/en not_active Expired - Lifetime
- 1995-06-06 CN CN95194461A patent/CN1053668C/zh not_active Expired - Lifetime
- 1995-06-06 PL PL95317726A patent/PL181867B1/pl unknown
- 1995-06-06 PT PT95920265T patent/PT787726E/pt unknown
- 1995-06-06 CA CA002192824A patent/CA2192824C/en not_active Expired - Lifetime
- 1995-06-06 DE DE69524251T patent/DE69524251T2/de not_active Expired - Lifetime
- 1995-06-06 SK SK1574-96A patent/SK281341B6/sk not_active IP Right Cessation
- 1995-06-06 MX MX9606331A patent/MX9606331A/es unknown
- 1995-06-06 ES ES95920265T patent/ES2163512T3/es not_active Expired - Lifetime
- 1995-06-06 EP EP95920265A patent/EP0787726B1/en not_active Expired - Lifetime
- 1995-06-06 AT AT95920265T patent/ATE209645T1/de active
- 1995-06-06 BR BR9508037A patent/BR9508037A/pt not_active IP Right Cessation
- 1995-06-06 JP JP50192396A patent/JP3391796B2/ja not_active Expired - Lifetime
- 1995-06-06 RU RU97100718/04A patent/RU2151770C1/ru active
- 1995-06-06 RO RO96-02349A patent/RO117793B1/ro unknown
- 1995-06-06 NZ NZ287139A patent/NZ287139A/en not_active IP Right Cessation
- 1995-06-06 DK DK95920265T patent/DK0787726T3/da active
- 1995-06-06 HU HU9603455A patent/HU220072B/hu unknown
- 1995-06-13 TW TW084106000A patent/TW319769B/zh not_active IP Right Cessation
1996
- 1996-12-11 NO NO965305A patent/NO307255B1/no not_active IP Right Cessation
- 1996-12-13 FI FI965020A patent/FI112485B/fi not_active IP Right Cessation
1997
- 1997-10-17 HK HK97101948A patent/HK1000495A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0787726A1 (en)	1997-08-06
SI0787726T1 (en)	2002-04-30
RO117793B1 (ro)	2002-07-30
US5817669A (en)	1998-10-06
AU679859B2 (en)	1997-07-10
FI112485B (fi)	2003-12-15
DK0787726T3 (da)	2002-02-11
NO965305L (no)	1997-02-04
AU2576795A (en)	1996-01-05
PL317726A1 (en)	1997-04-28
KR100350921B1 (ko)	2002-11-18
FI965020A (fi)	1996-12-16
CN1053668C (zh)	2000-06-21
PL181867B1 (pl)	2001-09-28
PT787726E (pt)	2002-04-29
RU2151770C1 (ru)	2000-06-27
JP3391796B2 (ja)	2003-03-31
WO1995034559A1 (fr)	1995-12-21
CA2192824A1 (en)	1995-12-21
HU9603455D0 (en)	1997-02-28
HK1000495A1 (en)	2002-07-19
ES2163512T3 (es)	2002-02-01
NZ287139A (en)	1997-07-27
SK281341B6 (sk)	2001-02-12
EP0787726B1 (en)	2001-11-28
CZ292631B6 (cs)	2003-11-12
DE69524251D1 (de)	2002-01-10
FI965020A0 (fi)	1996-12-13
TW319769B (no)	1997-11-11
SK157496A3 (en)	1997-08-06
CN1158614A (zh)	1997-09-03
EP0787726A4 (no)	1997-08-06
NO965305D0 (no)	1996-12-11
HU220072B (hu)	2001-10-28
BR9508037A (pt)	1997-09-16
CZ364396A3 (en)	1997-06-11
HUT75777A (en)	1997-05-28
ATE209645T1 (de)	2001-12-15
MX9606331A (es)	1997-03-29
DE69524251T2 (de)	2002-07-11
CA2192824C (en)	2006-11-07

Legal Events

Date	Code	Title	Description
2015-06-15	MK1K	Patent expired

Publication	Publication Date	Title
NO307255B1 (no)	2000-03-06	Nye forbindelser og antitumormidler
NO992549L (no)	1999-07-26	Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
DK0474243T3 (da)	1998-12-07	1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf
HUT59378A (en)	1992-05-28	Process for producing urea derivatives and pharmaceutical compositions comprising such compounds
NZ221699A (en)	1990-03-27	Pyridazinone derivatives; pharmaceutical compositions and intermediates
NO912462L (no)	1991-12-27	Fremstilling og anvendelse av bisfosfonsyrederivater.
YU165791A (sh)	1994-05-10	Postupak za pripremanje derivata 8-hlorohinolona
DK0812838T3 (da)	2002-08-19	Pyridoncarboxylsyrederivater substitueret med bicyclisk aminogruppe, estere og salte deraf og bicyclisk amin som mellemprodukt
DE3667788D1 (de)	1990-02-01	Diphenyletherherbizide.
ATE122683T1 (de)	1995-06-15	Epoxybernsteinsäurederivate, verwendbar als spezifische hemmer von cathepsin b.
EP1112998A4 (en)	2002-09-11	AMINE DERIVATIVES
MY104164A (en)	1994-02-28	Heterocyclic compounds.